Cleveland Cliffs Ord Shs (CLF)
$4.99 0.16 (3.11%)
17:32 EDT CLF Stock Quote Delayed 30 Minutes
Previous Close $5.15
Market Cap 1.49B
PE Ratio 4.38
Volume (Avg. Vol.) 11.08M
Day's Range 4.92 - 5.21
52-Week Range 2.63 - 11.61
Dividend & Yield N/A (N/A)
CLF Stock Predictions, Articles, and Cleveland Cliffs Ord Shs News
- From InvestorPlace
- From the Web
3 small-cap stocks to buy with strong financial profiles and attractive business outlooks that could be big long-term value creators.
Weak industry outlook will impact Cleveland-Cliffs's Q4 2019 results, but CLF stock looks positive beyond 2020 on automotive sector demand.
Should Lululemon be valued like Nike? If so, it could mean major upside. Here's what happened in the stock market today.
An AK Steel (AKS) buyout will have the steel company combining with Cleaveland-Cliffs (CLF) in a deal valued at $1.10 billion.
Options trading was buzzing in Cleveland-Cliffs, Home Depot, and Twitter Tuesday. Here are the metrics that matter moving forward.
Walmart, Twitter, Cleveland Cliffs and Invitae are our top stock trades for Wednesday. Here's what the charts say about them going forward.
Buying stocks that insiders are trading is one good strategy. These five stocks with high levels of insider trading are good buys, and cheap.
The markets have been shaky, but even without the help of tariff fears, these are 7 good stocks to sell to preserve your portfolio.
CLF stock is almost a great trade. Cleveland Cliffs just needs one good jolt from the right catalyst. Everything else is in place.
Electronic Arts, Cleveland-Cliffs, Expedia, Square and Roku are our top stock trades for Monday. Here's how to prepare for next week ...
Wall Street isn't much of a fan of CLF stock, but they're may be an underlying (bad) reasons.
Options trading was heavy in PG, CLF and PYPL following earnings releases. Here's how things stack up after Friday's volatile trading.
Electronic Arts broke below long-term support, Netflix has given up all of its earnings gains and P&G surged. Here's our top stock trades.
Among the two pillars of the U.S. economy, consumer confidence is strong and corporate earnings continue to grow. Compare Brokers....
Net income ratio gives us the exact profit level of a company and reflects the percentage of net income to total sales revenues. Compare Brokers....
Cleveland-Cliffs stock has rallied more than 40% so far in 2018. Given its growth though, investors may still be able to buy CLF stock.
The stock charts of Wells Fargo, Philip Morris and Gilead Sciences are shaping up as this week's most compelling prospects.
PsychedelicNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) Announces Regulatory Review
Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496), a human optimization sciences company with an emphasis on ketamine and psychedelic medicine, today announced that it has been selected for a continuous disclosure review by the British Columbia Securities Commission (the “Commission”). The review relates to Champignon’s disclosure obligations since it became a reporting issuer on […]
PsychedelicNewsBreaks – Champignon Brands Inc.’s (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) Dr. McIntyre / CRTCE Published in Two Peer Reviewed Study Journals
Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496), a human optimization sciences company with an emphasis on ketamine and psychedelic medicine, continues to highlight the scientific merit of its ketamine treatments for Major Depressive Disorder (“MDD”) while demonstrating rapid onset efficacy and safety of its treatment processes. To this accord, the Company today announced that […]
CannabisNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) Provides Corporate Update
Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496), a human optimization sciences company with an emphasis on ketamine and psychedelic medicine, on Friday provided a corporate update. Since commencing trading on March 2, 2020, the Company has expanded its initiatives and rapidly executed on such initiatives to position it as a leading publicly traded psychedelic medicine […]
Navellier RatingsPowered by Portfolio Grader